Medicare Enrolled

Dr. Christopher Wright, MD

Rheumatology · Dallas, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
8144 WALNUT HILL LN STE 800, Dallas, TX 75231
2145400700
In practice since 2009 (16 years)
NPI: 1356571087 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wright from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wright? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wright

Dr. Christopher Wright is a rheumatology in Dallas, TX, with 16 years in practice. Based on federal Medicare data, Dr. Wright performed 89,995 Medicare services across 2,923 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wright received a total of $10,111 from 31 pharmaceutical and/or device companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wright is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 17% volume in TX$ $10,111 industry payments

Medicare Practice Summary

Medicare Utilization ↗
89,995
Medicare services
Top 17% in TX for rheumatology
2,923
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,625 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Tocilizumab injection (Actemra)38,560$5$9
Golimumab infusion (Simponi Aria)22,800$10$40
Abatacept infusion (Orencia)8,475$34$83
Infliximab infusion (Remicade)5,940$26$90
Injection, rituximab, 10 mg5,600$63$145
Denosumab injection (Prolia/Xgeva)3,060$18$34
Office visit, established patient (30-39 min)651$88$210
Comprehensive metabolic blood panel606$10$28
C-reactive protein test (inflammation marker)602$5$15
Sed rate test (inflammation marker)596$3$7
Complete blood count (CBC) with differential577$8$16
Blood draw (venipuncture)351$8$12
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less244$51$155
Administration of chemotherapy into vein, 1 hour or less230$105$530
Administration of chemotherapy into vein, each additional hour227$22$66
Steroid injection (triamcinolone)152$1$6
Office visit, established patient, complex (40-54 min)149$128$276
Measurement of antibody for assessment of autoimmune disorder, any method147$18$32
Immunoglobulin level test98$9$20
Drug injection, under skin or into muscle95$11$57
Injection, methylprednisolone sodium succinate, up to 40 mg88$3$8
Injection of additional new drug or substance into vein87$12$46
Injection, zoledronic acid, 1 mg81$6$25
Office visit, established patient (20-29 min)65$58$145
Measurement of complement (immune system proteins), antigen,63$12$24
Analysis of substance using immunoassay technique, multiple step method44$11$21
Automated urinalysis43$2$6
New patient office visit (45-59 min)38$109$352
Vitamin D level test28$28$49
Total protein level, urine24$4$13
X-ray of hand, minimum of 3 views23$27$68
Creatine kinase (cardiac enzyme) level, total23$6$10
Creatinine test (kidney function)23$5$10
New patient office visit, complex (60-74 min)23$151$434
Measurement of antibody for rheumatoid arthritis assessment22$13$26
Measurement of dna antibody, native or double stranded22$13$28
Rheumatoid factor level22$6$15
Joint injection, major joint21$51$156
Measurement of dna antibody, single stranded21$12$25
Screening test for autoimmune disorder19$12$20
Flu vaccine administration16$31$63
Uric acid level test15$4$13
Flu vaccine, high-dose13$72$110
Tuberculosis test, gamma interferon11$61$120
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.6% high complexity
53.6% medium
4.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$10,111
Total received (2018-2024)
Avg $1,444/year across 7 years
Top 33% in TX for rheumatology
31
Companies
455
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,858 (77.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,252 (22.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,185
2023
$1,198
2022
$303
2021
$216
2020
$2,396
2019
$1,625
2018
$2,188

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Horizon Therapeutics plc
$2,451
Amgen Inc.
$1,394
Genentech USA, Inc.
$838
Lilly USA, LLC
$812
Novartis Pharmaceuticals Corporation
$672
ABBVIE INC.
$671
UCB, Inc.
$641
AbbVie Inc.
$336
GlaxoSmithKline, LLC.
$318
AbbVie, Inc.
$312
AstraZeneca Pharmaceuticals LP
$214
Actelion Pharmaceuticals US, Inc.
$199
Regeneron Healthcare Solutions, Inc.
$176
PFIZER INC.
$174
Janssen Biotech, Inc.
$131
Horizon Pharma plc
$116
SOBI, INC
$114
Ferring Pharmaceuticals Inc.
$79
Fresenius Kabi USA, LLC
$76
Radius Health, Inc.
$53
Zimmer Biomet Holdings, Inc.
$49
Organon Llc
$48
SANOFI-AVENTIS U.S. LLC
$40
Sobi, Inc
$35
Bayer HealthCare Pharmaceuticals Inc.
$32
E.R. Squibb & Sons, L.L.C.
$30
GENZYME CORPORATION
$24
Antares Pharma, Inc.
$24
Aurinia Pharma U.S., Inc.
$20
Celgene Corporation
$17
Medtronic, Inc.
$14
Top 3 companies account for 46.3% of total payments
Associated products mentioned in payments ›
ACTIVOS 10 BONE CEMENT · AVSOLA · Actemra · Adempas · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · Gel One · HADLIMA · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · Otrexup · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SKYRIZI · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tymlos · UPTRAVI · VISCO-3 · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a rheumatology in Dallas?
Compare rheumatologys in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
99
Per 100K population
3.8
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Wright is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Wright experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Wright performed 38,560 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wright receive payments from pharmaceutical companies?
Yes. Dr. Wright received a total of $10,111 from 31 companies across 455 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wright's costs compare to other rheumatologys in Dallas?
Dr. Wright's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wright) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →